Lexeo Therapeutics (LXEO) EPS (Weighted Average and Diluted): 2022-2023
Historic EPS (Weighted Average and Diluted) for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to $19.84.
- Lexeo Therapeutics' EPS (Weighted Average and Diluted) rose 323.93% to $19.84 in Q4 2023 from the same period last year, while for Dec 2023 it was -$12.40, marking a year-over-year change of. This contributed to the annual value of -$3.09 for FY2024, which is 75.08% up from last year.
- Per Lexeo Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at $19.84 for Q4 2023, which was up 260.52% from -$12.36 recorded in Q3 2023.
- In the past 5 years, Lexeo Therapeutics' EPS (Weighted Average and Diluted) ranged from a high of $19.84 in Q4 2023 and a low of -$12.36 during Q3 2023.
- In the last 2 years, Lexeo Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$9.62 in 2022 and averaged -$5.27.
- Examining YoY changes over the last 5 years, Lexeo Therapeutics' EPS (Weighted Average and Diluted) showed a top increase of 323.93% in 2023 and a maximum decrease of 19.08% in 2023.
- Lexeo Therapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at -$8.86 in 2022, then surged by 323.93% to $19.84 in 2023.
- Its EPS (Weighted Average and Diluted) was $19.84 in Q4 2023, compared to -$12.36 in Q3 2023 and -$8.30 in Q2 2023.